Free tool
Healthcare stocks
We cover 33 companies in the Healthcare sector. The median market value in the group is $4.05B. Across the group, the median move over the past trading day is −0.91%. 53% of the 32 with a 200-day average trade above it. Price change over the past year runs from −28.4% to +54.3% across the middle 80 percent of the group, with a median of +3.7%.
Other lists in this group
Table
33 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 4151.T | Kyowa Kirin Co., Ltd. | $8.51B | Mid cap | +4.01% |
| 4523.T | Eisai Co., Ltd. | $8.48B | Mid cap | +7.64% |
| RHC.AX | Ramsay Health Care Limited | $8.27B | Mid cap | +50.11% |
| 2413.T | M3, Inc. | $7.53B | Mid cap | −17.22% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +54.43% |
| 6869.T | Sysmex Corporation | $7.28B | Mid cap | +3.66% |
| SHL.AX | Sonic Healthcare Limited | $7.14B | Mid cap | −11.84% |
| 3391.T | Tsuruha Holdings Inc. | $6.89B | Mid cap | +5.97% |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | $6.82B | Mid cap | +15.35% |
| 7747.T | Asahi Intecc Co., Ltd. | $6.68B | Mid cap | +53.99% |
| 3088.T | MatsukiyoCocokara & Co. | $6.45B | Mid cap | −14.74% |
| COH.AX | Cochlear Limited | $6.39B | Mid cap | −53.79% |
| 326030.KS | SK Biopharmaceuticals Co., Ltd. | $4.89B | Mid cap | −11.24% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | $4.63B | Mid cap | +66.34% |
| 000100.KS | Yuhan Corporation | $4.50B | Mid cap | −27.54% |
| ANN.AX | Ansell Limited | $4.17B | Mid cap | +18.41% |
| 4506.T | Sumitomo Pharma Co., Ltd. | $4.05B | Mid cap | −3.59% |
| 000105.KS | Yuhan Corporation | $3.84B | Mid cap | −32.04% |
| TLX.AX | Telix Pharmaceuticals Limited | $3.82B | Mid cap | +4.88% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | $3.74B | Mid cap | +21.45% |
| 7459.T | MediPal Holdings Corporation | $3.72B | Mid cap | +13.38% |
| 3349.T | COSMOS Pharmaceutical Corporation | $3.26B | Mid cap | −26.59% |
| 7649.T | Sugi Holdings Co.,Ltd. | $3.13B | Mid cap | −28.60% |
| 9989.T | Sundrug Co.,Ltd. | $2.76B | Mid cap | −17.34% |
| EBO.AX | EBOS Group Limited | $2.60B | Mid cap | −37.83% |
| 2784.T | Alfresa Holdings Corporation | $2.53B | Mid cap | +6.80% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.44B | Mid cap | +5.23% |
| 009420.KS | Hanall Biopharma Co., Ltd. | $2.36B | Mid cap | +112.62% |
| MSB.AX | Mesoblast Limited | $2.25B | Mid cap | +1.03% |
| 302440.KS | SK bioscience Co.,Ltd. | $2.18B | Mid cap | −20.29% |
| 9987.T | Suzuken Co., Ltd. | $2.17B | Mid cap | −12.93% |
| 008930.KS | Hanmi Science Co., Ltd. | $2.11B | Mid cap | +2.80% |
| 6960.T | Fukuda Denshi Co., Ltd. | $2.02B | Mid cap | +79.12% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.